SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Press Releases Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.

Equities

2196

CNE100001M79

Delayed Hong Kong S.E. Other stock markets 23:30:58 2024-05-20 EDT			5-day change	1st Jan Change
13.04 ^HKD	-3.69%		-2.69%	-23.29%

05-15	Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment	MT
05-15	China Approves Clinical Trials For Breast Cancer Drugs	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Revance to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting	04-15	AQ
Shanghai Fosun Pharmaceutical : Fosun Pharma and Insightec Establish Joint Venture to Expand Global Access to Focused Ultrasound Treatment for Neurological Diseases	12-11	PU
Marubeni Corporation - Expansion of Pharmaceutical Business Initiatives	23-04-26	AQ
Fosun Pharma’s 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public	23-03-29	PU
Shanghai Fosun Pharmaceutical : COMIRNATY® Bivalent COVID-19 Vaccine is Officially Approved as Regular Imported Vaccine by the Pharmaceutical Administration Bureau of Macao SAR	23-01-20	PU
Syneos Health Announces Partnership with Fosun Pharma USA to Launch SerplulimabRelationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions	23-01-12	AQ
Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab	23-01-11	AQ
Shanghai Fosun Pharmaceutical : Self-Paid Vaccination Service for Bivalent COVID-19 Vaccine COMIRNATY® is Officially Provided in Hong Kong, Offering More Vaccine Options for People in Need	23-01-05	PU
Shanghai Fosun Pharmaceutical : Fosun Pharma Announces Results for the First Three Quarters of 2022	22-10-29	PU
Shanghai Fosun Pharmaceutical : Fosun Pharma’s MSCI ESG Rating Upgraded to A	22-10-13	PU
Neovii and Fosun Pharma Enter into an Exclusive Agreement	22-09-08	AQ
Shanghai Fosun Pharmaceutical : Fosun Pharma Topped the 2022 Fortune China ESG Impact List	22-08-25	PU
Shanghai Fosun Pharmaceutical : Fosun Pharma and Amgen Announce Collaboration to Accelerate Two Innovative Medicines Benefitting Chinese Patients	22-06-27	PU
Shanghai Fosun Pharmaceutical : Continuously Promoting Innovation and Internationalization Fosun Pharma Presents at 2022 BIO International Convention	22-06-17	PU
Shanghai Fosun Pharmaceutical : VOLUNTARY ANNOUNCEMENT - ENTERING INTO SALE AND PURCHASE AGREEMENTS （H SHARES）	22-06-06	PU
Shanghai Fosun Pharmaceutical : MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2022(H SHARES)	22-06-01	PU
Shanghai Fosun Pharmaceutical : (1) RE-APPOINTMENT OF CHAIRMAN AND VICE CHAIRMAN (2) APPOINTMENT OF CO-CHAIRMAN (3) APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND CO-CHIEF EXECUTIVE OFFICER AND (4) CHANGE IN BOARD COMMITTEE COMPOSITION	22-06-01	PU
Shanghai Fosun Pharmaceutical : Axicabtagene Ciloleucel - Fosun Kite's CAR-T Cell Therapy Approved to be Included in the 2022 Version of Shanghai “Huhuibao”	22-05-24	PU
Shanghai Fosun Pharmaceutical : Fosun Pharma and VerImmune enter into an Exclusive License and Option Agreement for VerImmune’s Virus-inspired Particle (ViP) platform as Novel Immunotherapies in China	22-05-19	PU
Shanghai Fosun Pharmaceutical : NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS (H SHARES)	22-04-28	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.

Equities

2196

CNE100001M79

Press Releases

Filters